CureGN-Diabetes Study: Rationale, Design, and Methods of a Prospective Observational Study of Glomerular Disease Patients with Diabetes

CureGN-Diabetes Study: Rationale, Design, and Methods of a Prospective Observational Study of Glomerular Disease Patients with Diabetes

Glomerular diseases (GDs) represent the third leading cause of end-stage kidney disease (ESKD) in the US Diabetes was excluded from the CureGN Study, an NIH/NIDDK-sponsored observational cohort study of four leading primary GDs: IgA nephropathy (IgAN), membranous nephropathy (MN), focal segmental gl...

Full description

Bibliographic Details
Main Authors: Amy K. Mottl, Andrew S. Bomback, Laura H. Mariani, Gaia Coppock, J. Charles Jennette, Salem Almaani, Debbie S. Gipson, Sara Kelley, Jason Kidd, Louis-Philippe Laurin, Krzysztof Mucha, Andrea L Oliverio, Matthew Palmer, Dana Rizk, Neil Sanghani, M.Barry Stokes, Katalin Susztak, Shikha Wadhwani, Cynthia C. Nast
Format: Article
Language:English
Published: Karger Publishers 2023-06-01
Series:Glomerular Diseases
Subjects:
glomerular disease
diabetes
cure glomerulonephropathy network
minimal change disease
focal segmental glomerulosclerosis
membranous nephropathy
iga nephropathy
iga vasculitis
Online Access:https://beta.karger.com/Article/FullText/531679

Internet

https://beta.karger.com/Article/FullText/531679

Similar Items